Verition Fund Management
BMY icon

Verition Fund Management’s Bristol-Myers Squibb BMY Stock Holding History

Verition Fund Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.6M Buy
75,800
+34,300
+83% +$2M 0.03% 620
2025
Q4 		$2.24M Sell
41,500
-6,600
-14% -$318K 0.01% 1501
2025
Q3 		$2.17M Buy
48,100
+8,400
+21% +$392K 0.01% 1907
2025
Q2 		$1.84M Buy
39,700
+7,400
+23% +$363K 0.01% 2019
2025
Q1 		$1.97M Buy
32,300
+23,500
+267% +$1.37M 0.01% 1584
2024
Q4 		$498K Hold
8,800
– – ﹤0.01% 2492
2024
Q3 		$455K Hold
8,800
– – ﹤0.01% 2373
2024
Q2 		$365K Sell
8,800
-6,100
-41% -$273K ﹤0.01% 2235
2024
Q1 		$808K Sell
14,900
-500
-3% -$25.5K 0.01% 1737
2023
Q4 		$790K Sell
15,400
-26,200
-63% -$1.38M 0.01% 1285
2023
Q3 		$2.41M Buy
+41,600
New +$2.55M 0.03% 702
2023
Q1 		– Sell
-14,600
Closed -$1.05M – 2168
2022
Q4 		$1.05M Sell
14,600
-7,200
-33% -$543K 0.02% 896
2022
Q3 		$1.55M Buy
+21,800
New +$1.58M 0.02% 1083
2022
Q2 		– Sell
-30,200
Closed -$2.21M – 2391
2022
Q1 		$2.21M Buy
30,200
+8,000
+36% +$537K 0.03% 898
2021
Q4 		$1.38M Buy
+22,200
New +$1.3M 0.01% 1096
2020
Q2 		– Sell
-255,500
Closed -$14.2M – 1064
2020
Q1 		$14.2M Sell
255,500
-797,900
-76% -$48.8M 0.56% 43
2019
Q4 		$67.1M Buy
1,053,400
+879,600
+506% +$50.4M 1.22% 17
2019
Q3 		$8.74M Buy
173,800
+52,500
+43% +$2.47M 0.24% 69
2019
Q2 		$5.5M Buy
+121,300
New +$5.65M 0.15% 105

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Verition Fund Management's BMY Position: Q1 2026 in Review

Verition Fund Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 39,989 shares — an estimated $2.33M sold.

Verition Fund Management first reported a position in BMY in Q3 2013 and held it in 37 quarters. The position peaked at $15.9M in Q3 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Verition Fund Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 39,989 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.33M.
  • Verition Fund Management first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 37 quarters.
  • Verition Fund Management's Bristol-Myers Squibb position peaked at $15.9M in Q3 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.